Li S - Search Results

1

Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.

Liu J, Li S, Zhang S, Liu Y, Ma L, Zhu J, Xin Y, Wang Y, Yang C, Cheng Y. Liu J, et al. Among authors: li s. J Clin Lab Anal. 2019 Oct;33(8):e22964. doi: 10.1002/jcla.22964. Epub 2019 Jul 8. J Clin Lab Anal. 2019. PMID: 31282096 Free PMC article.

2

Pretreatment prognostic nutritional index is a prognostic marker for extensive-stage small cell lung cancer patients treated with anlotinib.

Liu J, Li S, Zhang S, Yang C, Zhang L, Zhang B, Cheng Y, Wang C. Liu J, et al. Among authors: li s. J Thorac Dis. 2020 Oct;12(10):5765-5773. doi: 10.21037/jtd-20-755. J Thorac Dis. 2020. PMID: 33209408 Free PMC article.

3

Comparative Efficacy and Safety of TKIs Alone or in Combination With Antiangiogenic Agents in Advanced EGFR-Mutated NSCLC as the First-Line Treatment: A Systematic Review and Meta-Analysis.

Zhang S, Li S, Liu J, Yang C, Zhang L, Bao H, Cheng Y. Zhang S, et al. Among authors: li s. Clin Lung Cancer. 2022 Mar;23(2):159-169. doi: 10.1016/j.cllc.2021.06.001. Epub 2021 Jun 13. Clin Lung Cancer. 2022. PMID: 34247986

4

[Research Advances on Transformation to Small Cell Lung Cancer].

Zhang S, Li S, Cui Y, Cheng Y. Zhang S, et al. Among authors: li s. Zhongguo Fei Ai Za Zhi. 2021 Oct 20;24(10):729-733. doi: 10.3779/j.issn.1009-3419.2021.101.28. Zhongguo Fei Ai Za Zhi. 2021. PMID: 34696545 Free PMC article. Chinese.

5

[A Reflection of the New Wave of Immunotherapy on the Clinical Study of  Chinese Lung Cancer Immunotherapy].

Liu J, Zhang S, Li S, Cheng Y. Liu J, et al. Among authors: li s. Zhongguo Fei Ai Za Zhi. 2017 Oct 20;20(10):695-702. doi: 10.3779/j.issn.1009-3419.2017.10.06. Zhongguo Fei Ai Za Zhi. 2017. PMID: 29061217 Free PMC article. Review. Chinese.

6

[Research Progress of Immunotherapy for Brain Metastases in Patients  with Drive Gene Negative NSCLC].

Zhang S, Liu J, Yang C, Li S, Cheng Y. Zhang S, et al. Among authors: li s. Zhongguo Fei Ai Za Zhi. 2018 Aug 20;21(8):610-614. doi: 10.3779/j.issn.1009-3419.2018.08.06. Zhongguo Fei Ai Za Zhi. 2018. PMID: 30172268 Free PMC article. Review. Chinese.

7

Zhang L, Bai L, Liu X, Liu Y, Li S, Liu J, Zhang S, Yang C, Ren X, Cheng Y. Zhang L, et al. Among authors: li s. Thorac Cancer. 2020 May;11(5):1170-1179. doi: 10.1111/1759-7714.13370. Epub 2020 Mar 5. Thorac Cancer. 2020. PMID: 32134200 Free PMC article.

8

[Highlights of PAPR Inhibitors in Small Cell Lung Cancer].

Zhang S, Liu J, Yang C, Zhang L, Li S, Bao H, Cheng Y. Zhang S, et al. Among authors: li s. Zhongguo Fei Ai Za Zhi. 2020 Sep 20;23(9):806-810. doi: 10.3779/j.issn.1009-3419.2020.102.19. Epub 2020 Aug 5. Zhongguo Fei Ai Za Zhi. 2020. PMID: 32752582 Free PMC article. Review. Chinese.

9

Efficacy and safety of PD-1/PD-L1 inhibitor plus chemotherapy versus chemotherapy alone as first-line treatment for extensive-stage small cell lung cancer: A systematic review and meta-analysis.

Zhang S, Li S, Cheng Y. Zhang S, et al. Among authors: li s. Thorac Cancer. 2020 Dec;11(12):3536-3546. doi: 10.1111/1759-7714.13698. Epub 2020 Oct 15. Thorac Cancer. 2020. PMID: 33058504 Free PMC article.

10

The effect of PD-L1/PD-1 immunotherapy in the treatment of squamous non-small-cell lung cancer: a meta-analysis of randomized controlled clinical trials.

Li S, Zhang S, Liu J, Yang C, Zhang L, Cheng Y. Li S, et al. J Thorac Dis. 2019 Nov;11(11):4453-4463. doi: 10.21037/jtd.2019.11.12. J Thorac Dis. 2019. PMID: 31903233 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91,517 results

Search Page